These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3503969)

  • 1. [Production of rifamycin complex].
    Oner M; Tamer AU; Bursalioğlu M
    Mikrobiyol Bul; 1987 Oct; 21(4):296-300. PubMed ID: 3503969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of rifamycin B fermentation in shake flasks via a machine-learning-based approach.
    Bapat PM; Wangikar PP
    Biotechnol Bioeng; 2004 Apr; 86(2):201-8. PubMed ID: 15052640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structured kinetic model to represent the utilization of multiple substrates in complex media during rifamycin B fermentation.
    Bapat PM; Bhartiya S; Venkatesh KV; Wangikar PP
    Biotechnol Bioeng; 2006 Mar; 93(4):779-90. PubMed ID: 16302259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenesis of rifamycins. The conversion of rifamycin B into rifamycin Y.
    Lancini GC; Thiemann JE; Sartori G; Sensi P
    Experientia; 1967 Nov; 23(11):899-900. PubMed ID: 6056996
    [No Abstract]   [Full Text] [Related]  

  • 5. A cybernetic model to predict the effect of freely available nitrogen substrate on rifamycin B production in complex media.
    Bapat PM; Sohoni SV; Moses TA; Wangikar PP
    Appl Microbiol Biotechnol; 2006 Oct; 72(4):662-70. PubMed ID: 16534611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scale-up of rifamycin B fermentation with Amycolatoposis mediterranei.
    Jin ZH; Lin JP; Cen PL
    J Zhejiang Univ Sci; 2004 Dec; 5(12):1590-6. PubMed ID: 15547969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of rifamycin B activity in culture liquids and in preparations with varying degrees of purity].
    Makarova RA; Rezvan SP; Dzegilenko NB; Birlova LV; Chaĭkovskaia SM
    Antibiotiki; 1976 Aug; 21(8):685-8. PubMed ID: 11738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of balanced medium composition for improved rifamycin B production by isolated Amycolatopsis sp. RSP-3.
    Mahalaxmi Y; Sathish T; Prakasham RS
    Lett Appl Microbiol; 2009 Nov; 49(5):533-8. PubMed ID: 19793193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase shifts in the stoichiometry of rifamycin B fermentation and correlation with the trends in the parameters measured online.
    Bapat PM; Das D; Dave NN; Wangikar PP
    J Biotechnol; 2006 Dec; 127(1):115-28. PubMed ID: 16904217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stability of the antibiotic formation trait of the tobramycin producer Streptomyces cremeus subsp. tobramycini].
    Motkova MO; Gladkikh EG; Korobkova TP
    Antibiotiki; 1984 Feb; 29(2):83-5. PubMed ID: 6703668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the effect of barbital on Streptomyces mediterranei.
    Ruczaj Z; Ostrowska-Krysiak B; Sawnor-Korszyńska D; Raczyńska-Bojanowska K
    Acta Microbiol Pol B; 1972; 4(4):201-9. PubMed ID: 4405006
    [No Abstract]   [Full Text] [Related]  

  • 12. [The biogenesis of rifamycin S].
    Brufani M; Kluepfel D; Lancini GC; Leitich J; Mesentsev AS; Prelog V; Schmook FP; Sensi P
    Helv Chim Acta; 1973 Jul; 56(7):2315-23. PubMed ID: 4761273
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of phase shifts in batch fermentation via statistical analysis of the online measurements: a case study with rifamycin B fermentation.
    Doan XT; Srinivasan R; Bapat PM; Wangikar PP
    J Biotechnol; 2007 Oct; 132(2):156-66. PubMed ID: 17673325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of medium composition on the production of cephamycins by S. griseus and S. lactamdurans and the characterization of their growth.
    Malina HZ
    Acta Microbiol Pol; 1983; 32(4):353-62. PubMed ID: 6202103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oleandomycin content of mycelium and fermentation solution during cultivation of Streptomyces antibioticus].
    Shukoliukov SA; Sokolova IB
    Antibiotiki; 1984 Dec; 29(12):892-7. PubMed ID: 6395796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extraction of rifamycin B from native and aqueous solutions].
    Tolstykh IV; Konstantinova NV; Grishin IA; Pokras LS
    Antibiotiki; 1975 Mar; 20(3):222-5. PubMed ID: 237467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Actinomadura cremea var. rifamycini, a producer of rifamycin O].
    Gauze GF; Preobrazhenskaia TP; Lavrova NV; Ukholina RS; Kochetkova NV
    Antibiotiki; 1975 Nov; 20(11):963-6. PubMed ID: 1225170
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of nitrogen concentration in the medium on the composition of mycetine produced by Actinomyces violaceus].
    Bekhtereva MN; Iakubov GZ; Lovchikova AS; Feofilova EP; Tarasova NV; Khokhlova IuM; Khrzhanovskaia VE
    Mikrobiologiia; 1966; 35(3):413-21. PubMed ID: 6002901
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of various forms of inorganic nitrogen on the biosynthesis of rifamycin B].
    Lysko AV; Gorskaia SV
    Antibiot Med Biotekhnol; 1986 Jul; 31(7):519-21. PubMed ID: 3767329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimisation of nutritional requirements and process control parameters for the production of HA-2-91, a new tetraene polyene antibiotic.
    Gupte TE; Naik SR
    Hindustan Antibiot Bull; 1998; 40(1-4):5-13. PubMed ID: 16961200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.